1. Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway. (1st March 2022) Authors: Maurus, K.; Kosnopfel, C.; Kneitz, H.; Appenzeller, S.; Schrama, D.; Glutsch, V.; Roth, S.; Gerhard‐Hartmann, E.; Rosenfeldt, M.; Möhrmann, L.; Fröhlich, M.; Hübschmann, D.; Stenzinger, A.; Glimm, H.; Fröhling, S.; Goebeler, M.; Rosenwald, A.; Kutzner, H.; Schilling, B. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen‐activated protein kinase pathway. (21st December 2021) Authors: Maurus, K.; Kosnopfel, C.; Kneitz, H.; Appenzeller, S.; Schrama, D.; Glutsch, V.; Roth, S.; Gerhard‐Hartmann, E.; Rosenfeldt, M.; Möhrmann, L.; Fröhlich, M.; Hübschmann, D.; Stenzinger, A.; Glimm, H.; Fröhling, S.; Goebeler, M.; Rosenwald, A.; Kutzner, H.; Schilling, B. Journal: British journal of dermatology Issue: Volume 186:Number 3(2022) Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. (13th April 2020) Authors: Livingstone, E.; Zaremba, A.; Horn, S.; Ugurel, S.; Casalini, B.; Schlaak, M.; Hassel, J.C.; Herbst, R.; Utikal, J.S.; Weide, B.; Gutzmer, R.; Meier, F.; Koelsche, C.; Hadaschik, E.; Sucker, A.; Reis, H.; Merkelbach‐Bruse, S.; Siewert, M.; Sahm, F.; von Deimling, A. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. GNAQ and GNA11 mutant nonuveal melanoma: a subtype distinct from both cutaneous and uveal melanoma. (1st November 2020) Authors: Livingstone, E.; Zaremba, A.; Horn, S.; Ugurel, S.; Casalini, B.; Schlaak, M.; Hassel, J.C.; Herbst, R.; Utikal, J.S.; Weide, B.; Gutzmer, R.; Meier, F.; Koelsche, C.; Hadaschik, E.; Sucker, A.; Reis, H.; Merkelbach‐Bruse, S.; Siewert, M.; Sahm, F.; von Deimling, A. Journal: British journal of dermatology Issue: Volume 183:Number 5(2020) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Immunotherapy in melanoma: Recent advances and future directions. Issue 3 (March 2017) Authors: Franklin, C.; Livingstone, E.; Roesch, A.; Schilling, B.; Schadendorf, D. Journal: European journal of surgical oncology Issue: Volume 43:Issue 3(2017:Mar.) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. (1st September 2020) Authors: Weber, J.; Glutsch, V.; Geissinger, E.; Haug, L.; Lock, J.F.; Schneider, F.; Kneitz, H.; Goebeler, M.; Schilling, B.; Gesierich, A. Journal: British journal of dermatology Issue: Volume 183:Number 3(2020) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Nocardiosis in a patient with anti-PD-1–associated colitis treated with infliximab. (September 2018) Authors: Glutsch, V.; Gesierich, A.; Goebeler, M.; Forster, J.; Schilling, B. Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pembrolizumab‐associated mucous membrane pemphigoid in a patient with Merkel cell carcinoma. (1st October 2018) Authors: Haug, V.; Behle, V.; Benoit, S.; Kneitz, H.; Schilling, B.; Goebeler, M.; Gesierich, A. Journal: British journal of dermatology Issue: Volume 179:Number 4(2018) Page Start: 993 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Programmed death‐1 blockade for multiple basal cell carcinomas: clearing the field systemically?. (17th September 2018) Authors: Haug, V.; Schilling, B. Journal: British journal of dermatology Issue: Volume 179:Number 3(2018) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Programmed death‐1 blockade for multiple basal cell carcinomas: clearing the field systemically?. (1st September 2018) Authors: Haug, V.; Schilling, B. Journal: British journal of dermatology Issue: Volume 179:Number 3(2018) Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗